Haro Hartounian

Dr. Hartounian earned his Ph.D. in Chemical Engineering from the University of Delaware. He leads the Biopharma Division at NJII, working with colleagues in industry and academia to help biopharmaceutical companies transform discovery into commercial production. He has 30 years of experience in the biotechnology industry working for companies such as DuPont, Monsanto, SkyePharma and Vyteris. He also founded the companies MicroIslet, Protagenic Therapeutics, and DiaVacs and has worked in a variety of product lines — including cell therapy, oncology, women’s health, pain management and drug delivery. In addition, Dr. Hartounian is an adjunct associate professor of Chemical Engineering at Columbia University, and is on the Affiliated Faculty in NJIT’s Department of Chemistry and Environmental Science.

BioCentriq in 2022

A Message from CEO and Founder Haro Hartounian, Ph.D. 2022 has already been a year packed with growth and advancement, fueled by the need for regenerative medicine and the individuals working to bring new therapies …

Read more